Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Vonavir Efavirenz, Emtricitabine, and Tenofovir Tablets IP
Vonavir, offered by Lexaro Healthcare, contains a fixed-dose combination of Efavirenz, Emtricitabine, and Tenofovir in each tablet. This combination is specifically formulated to provide comprehensive antiretroviral therapy for the treatment of HIV-1 infection, enhancing viral suppression and improving patient adherence.
Uses of Vonavir Efavirenz, Emtricitabine, and Tenofovir Tablets IP
Vonavir is primarily prescribed for:
Treating HIV-1 infection in adults and adolescents.
Reducing the viral load and increasing the CD4 cell count in HIV-1 infected individuals.
Preventing the progression to AIDS and related complications.
Offering a convenient single-tablet regimen for enhanced patient adherence.
Benefits of Vonavir Efavirenz, Emtricitabine, and Tenofovir Tablets IP
Combines three antiretroviral agents for a comprehensive approach to managing HIV-1 infection.
Provides effective viral suppression and helps increase CD4 cell counts.
Reduces the risk of developing drug-resistant strains of HIV-1.
Offers a convenient single-tablet regimen, improving patient adherence to therapy.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Vonavir Efavirenz, Emtricitabine, and Tenofovir Tablets IP
Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works by binding to the reverse transcriptase enzyme, preventing the conversion of viral RNA into DNA. This inhibition blocks viral replication and reduces the viral load.
Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) that works by incorporating itself into the viral DNA chain, leading to chain termination and preventing further viral replication.
Tenofovir is a nucleotide reverse transcriptase inhibitor (NtRTI) that interferes with the reverse transcription process by incorporating into the viral DNA, causing chain termination and inhibiting viral replication.